Technical Overview

In the pharmaceutical and biotechnology sectors, water is the most widely used raw material. Its quality must comply with rigorous pharmacopoeial standards (USP, EP, JP) to ensure patient safety and product efficacy. The two primary grades are Purified Water (PW), used for non-parenteral products and cleaning, and Water for Injection (WFI), required for parenteral (injectable) drugs.

Purification and Microbial Control

PW is typically produced using a combination of softening, carbon filtration, two-pass Reverse Osmosis (RO), and Continuous Electrodeionization (CEDI). The primary challenge is not just ionic purity, but the prevention of biofilm formation. Pharmaceutical water loops are designed as continuous recirculating systems with high-velocity flows to prevent stagnation. Sanitization is a critical operational requirement, with most modern systems using either periodic Hot Water Sanitization (>80°C) or continuous/periodic Ozone (O3) treatment coupled with UV-destruct units.

The “Cold WFI” Revolution

Historically, WFI could only be produced by distillation (Multi-Effect Distillation), which is energy-intensive. Recent changes to the European Pharmacopoeia (and long-standing USP rules) now allow “Cold WFI” production via membrane-based processes. A typical Cold WFI train adds an extra layer of security—usually Ultrafiltration (UF)—after the CEDI stage to ensure the total removal of endotoxins (lipopolysaccharides from bacterial cell walls). This shift has significantly reduced the carbon footprint of biotech facilities.

Validation and Compliance

Every pharmaceutical water system must undergo a rigorous three-phase validation process: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Continuous monitoring of TOC and Conductivity is mandated by USP <643> and <645>. Any deviation from established “Alert” and “Action” limits requires a formal deviation investigation. Emerging trends include the adoption of “Rapid Microbiological Methods” (RMM), which use laser-induced fluorescence to detect bacteria in real-time, providing an alternative to the traditional 5-day agar plate count.